Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients

Journal of B.U.ON.

Volumn 15, Issue 2, 2010, Pages 330-336

  Zelen, Ivanka ^a   Djurdjevic, P ^a   Popovic, S ^a   Stojanovic, M ^a   Jakovljevic, V ^a   Radivojevic, S ^b   Baskic, D ^a   Arsenijevic, N ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b CLINICAL CENTER KRAGUJEVAC   (Serbia)

Author keywords

Catalase; Chronic lymphocytic leukemia; Glutathione peroxidase; Malondialdehyde; Reactive oxygen species; Superoxide dismutase

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; MALONALDEHYDE; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS;

CATALASE; GLUTATHIONE PEROXIDASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LIPID PEROXIDATION; NEOPLASM STAGING; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 77954413842     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Dönner H, Stilgenbauer S, Benner A et al. Genomic aberration and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910-1916. (Pubitemid 32064784)
2. Meinhardt G, Wendtner C, Hallek M. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J Mol Med 1999; 77: 282-293. (Pubitemid 29146579)
3. Rai K, Peterson B, Appelbaum F et al. Fludarabin compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750-1757.
4. Kipps T. Chronic lymphocytic leukemia. Curr Opin Hematol 2000; 7: 223-232.
5. Kostareli E, Smilevska T, Stamatopoulos K, Kouvatsi A, Anagnostopoulos A. Chronic lymphocytic leukaemia: an immunobiology approach. Srp Arh Celok Lek 2008; 136(5-6): 319-323 (in Serbian).
6. Eisterer W, Bechter O, Söderberg O et al. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukemia. Leukemia Res 2004; 28: 1043-1051.
7. Jones DT, Geneshaguru K, Anderson RJ et al. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 2003; 101: 3174-3180.
8. Mentz F, Mossalayi D, Quaaz f et al. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood 1996; 88: 2172-2182.
9. Dierlamm J, Michaux L, Oriel A et al. Genetic abnormalities in chronic lymphocytic leukemia and their critical and prognostic implications. Cancer Genet Cytogenet 1997; 94: 27-35. (Pubitemid 27133498)
10. Guyton KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 1993; 49: 523-543.
11. Halliwell B, Gutteridge JMC (Eds). Free Radicals in Biology and Medicine (3rd Edn). Oxford University Press, New York, 1999.
12. Kostic N, Caparevic Z, Ilic S. Antioxidant status in type II diabetes mellitus with or without microvascular complications. Srp Arh Celok Lek 2007; 135(3-4): 143-146 (in Serbian).
13. Vergani L, Floreani M, Russell A et al. Antioxidant defences and homeostasis of reactive oxygen species in different human mitochondrial DNA-depleted cell lines. Eur J Biochem 2004; 271: 3646-3656. (Pubitemid 39233606)
14. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003; 15: 247-254.
15. Forman HJ, Torres M, Fukuto J. Redox signaling. Mol Cell Biochem 2002; 234-235: 49-62.
16. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001; 11: 173-186. (Pubitemid 32786086)
17. Cheson BD, Bennet JM, Grever M et al. National Cancer Institute-sponsored Working Group guidelines for clinical protocols for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997. (Pubitemid 26189840)
18. Binet JL, Auquier A, Dighiero G et al. A new prognostic classification of chronic lymphocytic leukemia derived from multivariate analysis. Cancer 1981; 48: 198-206. (Pubitemid 11064396)
19. Woolliams JA, Wiener G, Anderson PH, McMurray CH. Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep. Res Vet Sci 1983; 34: 253-256. (Pubitemid 13070011)
20. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
21. Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991; 196: 143-152.
22. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenwald RA (Ed): Handbook of methods for oxygen radical research. CRC Press Inc, Boka Raton, 1985, pp 123-132.
23. Pick E, Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cell in culture. J Immunol Meth 1980; 38: 161-170. (Pubitemid 11251411)
24. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxide s in animal tissue by thiobarbituric acid reaction. Ann Biochem 1979; 95: 351-358. (Pubitemid 9194347)
25. Toyokuni S, Okamoto K, Yodoy J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995; 16: 3581-3583.
26. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide in human tumor cells. Cancer Res 1991; 51: 794-798.
27. Carew JS, Nawrocki St, Xu Rh et al. Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine. Leukemia 2004; 18: 1934-1340.
28. Bakan T, Taysi S, Yilmaz O et al. Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide and malondialdehyde concentration in serum of patients with chronic lymphocytic leukemia. Clin Chim Acta 2003; 338: 143-149. (Pubitemid 37456701)
29. Moran EC, Kamiguti AS, Cawley JC, Pettitt AR. Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic leukemia. Br J Haematol 2002; 116: 316-328.
30. Purdue PE, Lazarow PB. Targeting of human catalase to peroxisomes is dependent upon a novel CCOH-terminal peroxisomal targeting sequence. J Cell Biol 1996; 134: 814-822.
31. Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum free medium. Proc Natl Acad Sci USA 1993; 90: 4708-4712.
32. Arivazhagan S, Kavitha K, Nagini S. Erythrocyte lipid peroxidation and antioxidants in gastric cancer patients. Cell Biochem Funct 1997; 15: 15-18. (Pubitemid 27116527)
33. Latha B, Babu M. The involvement of free radicals in burn injury: a review. Bums 2001; 27: 309-317. (Pubitemid 32451669)
34. Devi GS, Prasad MH, Sarawathi I, Raghu D,Rao DN, Reddy PP. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin Chim Acta 2000; 293: 53-62.
35. Oltra A, Carbonell F, Tormos C, Iradi A, Saez G. Antioxidant enzyme activities and the production of the MDA and 8-oxoDG in chronic lymphocytic leukemia. Free Radic Biol Med 2001; 30: 1286-1292.
36. Djurdjevic P, Zelen I, Ristic P et al. Oxidative stress markers in chronic lymphocytic leukemia. Medicus 2006; 7: 52-56. (Pubitemid 44133507)
37. Djurdjevic P, Zelen I, Ristic P et al. Oxidative stress accelerates spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes. J BUON 2009; 14: 281-287.
38. Seven A, Civelek S, Inci E et al. Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma. Clin Biochem 1999; 32: 369-373. (Pubitemid 29416728)
39. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999; 424: 83-95.